Validation of production processes in the pharmaceutical industry: brief history and current aspects
DOI:
https://doi.org/10.14450/2318-9312.v35.e4.a2023.pp489-501Keywords:
Process Validation, Pharmaceutical Industry, Quality ManagementAbstract
The validation of production processes in the pharmaceutical industry is part of a set of standards and tools used to ensure the quality of pharmaceutical products, being an integral part of Good Manufacturing Practices (GMP). This work aims to contextualize the history and concepts involved in the production validation processes in Brazil, from the creation of the National Health Surveillance Agency (Anvisa) to the present day. Anvisa’s Resolutions published on the subject, guides from the International Council of Harmonization (ICH), and other references related to the matter, which are available in PubMed and Scielo databases, were evaluated. Through the analysis carried out, it is noticeable that the level of complexity involved in the validation of productive processes has increased since the first Resolution of the Collegiate Board (RDC) no. 134 of 2001 which addressed concurrent and prospective modes related to processes and products, as well as a retrospective format based on historical product data. With the updates, namely: RDC no. 210/2003, RDC no. 17/2010, RDC no. 301/2019, and RDC no. 658/2022, the use of quality management tools was improved, with the verification of processes, through analytical and statistical tools. In this way, it is necessary to maintain the constant improvement of both the production processes and their regulation and the research and dissemination of knowledge involved in the manufacture of medicines.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).